Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel
Dongwei Kang(Shandong University), Peng Zhan(Shandong University of Traditional Chinese Medicine), Francesc X. Ruiz(Rutgers, The State University of New Jersey), Erik De Clercq(Rega Institute for Medical Research), Xinyong Liu(Shandong University of Traditional Chinese Medicine), Fenju Wei(Shandong University), Zengjun Fang(Second Hospital of Shandong University), Eddy Arnold(Rutgers, The State University of New Jersey), Zhao Wang(Shandong University), Da Feng(Shandong University), Yanying Sun(Shandong University), Alyssa Pilch(Rutgers, The State University of New Jersey), Tong Zhao(China Pharmaceutical University), Christophe Pannecouque(Rega Institute for Medical Research)
Cited by 47
Related Papers
Therapeutic strategies for COVID-19: progress and lessons learned
|Nature Reviews Drug Discovery|2023|671
Antiviral agents active against influenza A viruses
|Nature Reviews Drug Discovery|2006|666
Overview of Recent Strategic Advances in Medicinal Chemistry
|Journal of Medicinal Chemistry|2019|181
Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent
|Antimicrobial Agents and Chemotherapy|2008|115
New Class of HIV Integrase Inhibitors that Block Viral Replication in Cell Culture
|Current Biology|2002|100